Source comparison
Real Peptides CJC-1295 no DAC & Ipamorelin vs Competitors Quality: Comparison
The comparison below isolates the quality markers that predict experimental reproducibility. Price and shipping speed matter. But they're secondary to whether the peptide in your vial matches the structure you're paying for. HPLC Purity Verification 99.2% mini
This comparison does not assign a generated winner or score.
- The comparison below isolates the quality markers that predict experimental reproducibility. Price and shipping speed matter. But they're secondary to whether the peptide in your vial matches the structure you're paying for.
- HPLC Purity Verification
- 99.2% minimum, third-party tested per batch
- 95–98% claimed, testing method unspecified
- 'Research grade' claimed, no COA provided
- Impurities below 98% include deletion sequences that compete for receptor binding without biological activity
- Mass Spectrometry Confirmation
- Performed on every batch, MW within 0.01% tolerance
- Performed on initial synthesis only
- Not routinely performed
- Confirms actual molecular structure vs structural isomers with identical HPLC profiles
- Endotoxin Testing
- <0.5 EU/mg via LAL assay, batch-specific
- <1.0 EU/mg claimed, no batch documentation
- Not tested or disclosed
- Endotoxin contamination above 1 EU/mg triggers inflammatory responses in cell culture and animal models
- Peptide Content Assay
- 95–105% of stated mass is active peptide
- Not disclosed. Total powder weight may include salts
- Not performed
- 10mg vial with 70% peptide content delivers 7mg active compound. Dosing calculations fail
- Synthesis Method
- Small-batch SPPS with Fmoc chemistry
- Contract manufacturing, method undisclosed
- Unknown. Likely bulk liquid-phase
- Liquid-phase increases deletion sequence formation; large batches reduce QC oversight per unit
- Storage Recommendations
- −20°C before reconstitution, 2–8°C after, use within 28 days
- 'Store frozen'. No stability data provided
- No storage guidance included
- Peptides stored improperly lose 15–25% potency before use. Experimental dosing becomes guesswork
- Professional Assessment
- Meets institutional research standards with full traceability and third-party verification at every batch. Built for reproducibility
- Acceptable for preliminary screening where minor purity variance won't invalidate results. Documentation gaps prevent use in GLP protocols
- Unreliable for any research requiring reproducibility or regulatory compliance. Quality claims unverifiable
- Quality variance compounds across multi-month studies. Starting with verified purity eliminates this variable entirely